MGC Pharmaceuticals Ltd – Prospectus
ONLINE DISCLAIMER – ACCESS TO THE PROSPECTUS AS SUPPLEMENTED BY THE SUPPLEMENTARY PROSPECTUS FROM MGC PHARMACEUTICAL’S WEBSITE
YOU MUST READ THIS IMPORTANT NOTICE BEFORE YOU ATTEMPT TO ACCESS A COPY OF THE PROSPECTUS AND THE SUPPLEMENTARY PROSPECTUS ON THIS WEBSITE. THE MATERIALS MAY NOT BE ACCESSED IN WHOLE OR IN PART BY ANY PERSON IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.
BY ACCESSING THE PROSPECTUS AND THE SUPPLEMENTARY PROSPECTUS (BY CLICKING THE LINK BELOW) YOU ACKNOWLEDGE THAT YOU HAVE READ AND ACCEPT THE TERMS SET OUT IN THIS NOTICE.
MGC Pharmaceuticals Ltd (Company) Prospectus for an offer of 500,000 Shares at an issue price of $0.02 each to raise $10,000 (before costs) (Public Offer).
The Prospectus is dated 18 December 2015. On 11 February 2016, the Company lodged a supplementary prospectus with ASIC that is to be read together with the Prospectus (Supplementary Prospectus). The document accessible from this website is an electronic version of the Prospectus as supplemented by the Supplementary Prospectus and is an important document.
The Prospectus also contains:
- an offer of 200,000,000 Shares and 100,000,000 Performance Shares to the Vendors (or their nominees) in consideration for the acquisition of all the issued capital in MGC; and
- an offer of 20,000,000 New Options to the sub-underwriters of the exercise of the Company’s Options that expired on 30 June 2015,
(together with the Public Offer, the Offers).
The expiry date of the Prospectus is the date that is 13 months from the date of the Prospectus.
This is an important document that should be read in its entirety. If you do not understand it you should consult your professional adviser without delay.
Lodgement of Prospectus with the ASIC
The paper form of the electronic Prospectus as supplemented by the Supplementary Prospectus accessible through this website has been lodged with the Australian Securities and Investments Commission (ASIC).
An application for shares under the Public Offer can be made by either:
- printing and completing the Public Offer Application Form attached to or accompanied by the electronic Prospectus as supplemented by the Supplementary Prospectus; or
- completing the Public Offer Application Form attached to or accompanied by a paper form of the Prospectus as supplemented by the Supplementary Prospectus,
and then lodging the form and the application monies in accordance with the details set out in the Prospectus as supplemented by the Supplementary Prospectus and the Public Offer Application Form.
For legal reasons, the information and electronic Prospectus as supplemented by the Supplementary Prospectus provided by this website is available to persons accessing this website from within AUSTRALIA ONLY. If you are accessing this website from anywhere outside Australia, please DO NOT download the electronic Prospectus or the Supplementary Prospectus accessible through this website.
This Prospectus as supplemented by the Supplementary Prospectus does not constitute an offer of securities in any jurisdiction where, or to any person to whom, it would not be lawful to issue the Prospectus as supplemented by the Supplementary Prospectus or make the Offers. It is the responsibility of any applicant outside Australia to ensure compliance with all laws of any country relevant to their applications, and any such applicant should consult their professional advisers as to whether any government or other consents are required, or whether any formalities need to be observed to enable them to apply for and be issued any securities.
No action has been taken to register or qualify the securities or the Offers or otherwise to permit a public offering of the securities in any jurisdiction outside Australia.
I AGREE TO AND CONFIRM THE ABOVE – CLICK HERE TO VIEW THE PROSPECTUS AS SUPPLEMENTED BY THE SUPPLEMENTARY PROSPECTUS